PSYGF Psyence Group Inc

USD 0.02 0.00 0
Icon

Psyence Group Inc (PSYGF) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.02

0.00 (0.00)%

USD 3.06M

N/A

N/A

N/A

Icon

PSYGF

Psyence Group Inc (USD)
COMMON STOCK | OTC
USD 0.02
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 3.06M

N/A

USD 0.02

Psyence Group Inc (PSYGF) Stock Forecast

N/A

Based on the Psyence Group Inc stock forecast from 0 analysts, the average analyst target price for Psyence Group Inc is not available over the next 12 months. Psyence Group Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Psyence Group Inc is Very Bearish, which is based on 0 positive signals and 7 negative signals. At the last closing, Psyence Group Inc’s stock price was USD 0.02. Psyence Group Inc’s stock price has changed by +79.84% over the past week, -28.17% over the past month and -80.12% over the last year.

No recent analyst target price found for Psyence Group Inc
No recent average analyst rating found for Psyence Group Inc

Company Overview Psyence Group Inc

Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is devel...Read More

https://www.psyence.com

121 Richmond Street West, Toronto, ON, Canada, M5H 2K1

0

March

USD

USA

Adjusted Closing Price for Psyence Group Inc (PSYGF)

Loading...

Unadjusted Closing Price for Psyence Group Inc (PSYGF)

Loading...

Share Trading Volume for Psyence Group Inc Shares

Loading...

Compare Performance of Psyence Group Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PSYGF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Psyence Group Inc (Sector: Drug Manufacturers - General )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
RHHVF
Roche Holding AG Participation 0.00 (0.00%) USD227.02B 17.92 12.62

ETFs Containing PSYGF

Symbol Name PSYGF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Psyence Group Inc (PSYGF) Stock

Stock Target Advisor's fundamental analysis for Psyence Group Inc's stock is Very Bearish.

Unfortunately we do not have enough data on PSYGF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on PSYGF's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on PSYGF's stock to indicate if its overvalued.

The last closing price of PSYGF's stock was USD 0.02.

The most recent market capitalization for PSYGF is USD 3.06M.

Unfortunately we do not have enough analyst data on PSYGF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Psyence Group Inc's stock.

As per our most recent records Psyence Group Inc has 0 Employees.

Psyence Group Inc's registered address is 121 Richmond Street West, Toronto, ON, Canada, M5H 2K1. You can get more information about it from Psyence Group Inc's website at https://www.psyence.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...